Samsung Electro-Mechanics Unveils World's First MLCC for LiDAR Applications
Development of MLCC for LiDAR, a Key Device in Autonomous Driving Samsung Electro-Mechanics expanding its range of Automotive Multilayer Ceramic Capacitors(MLCC) with the groundbreaking new 2.2uF high-capacity, high reliability and the most highest...
Clarifai Partners with Arrow Electronics to Accelerate Commercial AI Adoption and Distribution
Clarifai's Full-Stack AI Platform Now Available to Arrow's Global Distribution Network to Orchestrate Scalable AI Solutions Across Industries WASHINGTON, Feb. 5, 2025 /PRNewswire/ -- Clarifai, a global leader in AI and pioneer of the full-stack AI...
IRCODE INTRODUCES LIVE+: A NEW STANDARD FOR REAL-TIME INTERACTION AND LIVE COMMERCE
HOUSTON, Feb. 5, 2025 /PRNewswire/ -- IRCODE, a game-changing technology redefining the boundaries of live sports and interactive media, has announced the launch of LIVE+, a new capability designed to integrate real-time interactivity into live...
Datasea Pre-Announces Second Quarter Revenue of $20.5 Million, up 81% Year-over-Year
Gross Profit achieved a 310% Increase Year-over-Year BEIJING, Feb. 5, 2025 /PRNewswire/ -- Datasea Inc. (Nasdaq: DTSS) ("Datasea" or "the Company"), a Nevada-based digital technology company specializing in acoustics high-tech and 5G+AI multimodal...
Actinogen announces new and unique nonproprietary name of 'emestedastat' for Xanamem
Late-stage Alzheimer's trial opens 10 new sites in USA, with results due in 2025 and 2026 SYDNEY, Feb. 5, 2025 /PRNewswire/ -- Actinogen Medical Limited (ASX: ACW) announces that the World Health Organization (WHO) has granted the nonproprietary...
Supermicro Ramps Full Production of NVIDIA Blackwell Rack-Scale Solutions with NVIDIA HGX B200
Supermicro Offers Next-Generation Air-Cooled and Liquid-Cooled Architecture for NVIDIA Blackwell Platform SAN JOSE, Calif., Feb. 5, 2025 /PRNewswire/ -- Supermicro, Inc. (NASDAQ: SMCI), a Total IT Solution Provider for AI/ML, HPC, Cloud, Storage,...
Serplulimab Approved in the EU for First-Line Treatment of Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
Serplulimab is the world's first anti-PD-1 monoclonal antibody (mAb) approved for first-line treatment of ES-SCLC Serplulimab is the first and only anti-PD-1 mAb approved in the European Union (EU) for the treatment of ES-SCLC Serplulimab has now...
NYSE CONTENT ADVISORY: PRE-MARKET UPDATE FOR FEBRUARY 5th
NEW YORK, Feb. 5, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) is proud to offer a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins....